Results 261 to 270 of about 42,960 (301)
Some of the next articles are maybe not open access.
Advanced Glycation End Products and Bone Loss during Aging
Annals of the New York Academy of Sciences, 2005Abstract: It is well known that bone mass density decreases with age. Age‐related bone mass loss is ascribed to several factors. Nonenzymatic glycation has been proposed as a new potential factor in the loss of bone during aging. In this study we evaluated the concentration of pentosidine, an advanced glycation end product, in cortical and trabecular ...
ODETTI, PATRIZIO +6 more
openaire +3 more sources
Bone Aging by Advanced Glycation End Products
Journal of Dental Research, 2015The quality and quantity of mandibular bone are essential prerequisites for osseointegrated implants. Only the Hounsfield unit on preoperative computed tomography is currently used as a clinical index. Nevertheless, a considerable mismatch occurs between bone quality and the Hounsfield unit.
K, Ganeko +7 more
openaire +2 more sources
Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases
Amino Acids, 2007Advanced glycation end-products (AGEs) are formed from the so-called Amadori products by rearrangement followed by other reactions giving rise to compounds bound irreversibly. The structure of some of them is shown and the mechanism of formation is described.
M.A. GRILLO, COLOMBATTO, Sebastiano
openaire +2 more sources
Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Current Pharmaceutical Design, 2008Advanced glycation end products (AGEs) are a heterogeneous group of molecules, formed in vivo both by non-oxidative and oxidative reactions of sugars and their adducts to proteins and lipids. It is now well established that formation and accumulation of AGEs progress during normal aging, and at an extremely accelerated rate under diabetes, thus being ...
Hideyuki, Hyogo, Sho-ichi, Yamagishi
openaire +2 more sources
Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation
2020A range of chemically different compounds are known to inhibit the formation and accumulation of advanced glycation end products (AGEs) or disrupt associated signalling pathways. There is evidence that some of these agents can provide end-organ protection in chronic diseases including diabetes.
Karly C, Sourris +2 more
openaire +2 more sources
Advanced Glycation End Products of the Maillard Reaction and Their Relation to Aging
Gerontology, 1994Long-term incubation of proteins with glucose leads to advanced glycation end products (AGE). Demonstration of AGE in vivo as well as determination of its main structure are crucial to elucidate its potential link to aging processes and diabetic complications.
S, Horiuchi, N, Araki
openaire +2 more sources
Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications
Current Diabetes Reviews, 2005Diabetic vascular complication is a leading cause of acquired blindness, end-stage renal failure, a variety of neuropathies and accelerated atherosclerosis, which could account for disabilities and high mortality rates in patients with diabetes. Chronic hyperglycemia is essentially involved in the development and progression of diabetic micro- and ...
Sho-ichi, Yamagishi +2 more
openaire +2 more sources
Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease
Current Alzheimer Research, 2004The advanced stage of the glycation process (one of the post-translational modifications of proteins) leads to the formation of advanced glycation end-products (AGEs) and plays an important role in the pathogenesis of angiopathy in diabetic patients.
Masayoshi, Takeuchi +7 more
openaire +2 more sources
Advanced Glycation End Products, RAGE, and Aging
2010The products of nonenzymatic glycation and oxidation of proteins and lipids, the advanced glycation end products (AGEs), accumulate in diverse biological settings including aging. AGEs may be generated rather quickly or over long duration as a consequence of distinct triggering mechanisms, thereby accounting for their roles in multiple settings and ...
Ravichandran Ramasamy +3 more
openaire +1 more source
The role of advanced glycation end products in retinal ageing and disease
Biochimica et Biophysica Acta (BBA) - General Subjects, 2009The retina is exposed to a lifetime of potentially damaging environmental and physiological factors that make the component cells exquisitely sensitive to age-related processes. Retinal ageing is complex and a raft of abnormalities can accumulate in all layers of the retina.
Glenn, Josephine V., Stitt, Alan W.
openaire +3 more sources